wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trevor john wilkinson who wrote ()	12/27/1999 5:31:00 PM
From: John Romeo	of 942

Interesting note on Drug Sector was upgraded today. Most large cap drug firms were up a point or more except AHP which was down -1 1/4 to $38 a fifty two week low, and intraday low of $36 1/2.FYI News December 27, 09:24 Eastern Time RESEARCH ALERT -Drug stocks recommended after drop CHICAGO, Dec 27 (Reuters) - ABN AMRO analyst James Keeney said Monday he sees a buying opportunity for high-quality drug stocks, following an 11 percent decline in 1999 in the sector. -- said ABN's core drug index of eight multinational drug companies was down mostly because of Medicare concerns and a flow of funds to the technology sector. -- said final Medicare proposal for prescription drug coverage for the elderly will "be more to the industry's liking than previous proposals - and still probably two years off any enactment." -- said top picks are buy-rated Bristol-Myers Squibb Co; outperform-rated American Home Products Corp. ;a merged Pharmacia & Upjohn Inc. ; and in the small-cap area, Maxim Pharmaceuticals Inc. . ((--Kathy Fieweger, Chicago Equities News at 312 408 8787, chicago.equities.newsroom@reuters.com))

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next